Tagged with Science

Spain Cédric Ertlé, general director of Laboratoires Expanscience Iberia, talks about his strategy to turn around the affiliate’s dermo cosmetic range in what is a shrinking Spanish market and his goal of introducing a rheumatology portfolio, as he did in Mexico. Furthermore, he discusses the importance of being a B-Corp company.…

France Lundbeck France and Benelux’s Lourdes Pla discusses Europe-wide restructuring, the importance of the French affiliate to the global group and the government’s attitude towards healthcare and neuroscience.   We are the only specialty pharma player exclusively dedicated to neuroscience and it is important that this shines through in our dealings…

Hong Kong Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate.   Having had the experience of opening the affiliate in Brazil, in addition to your in-depth understanding of other emerging markets, what were the key skills you…

Turkey Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare system could benefit from critical products which are not often considered to have strong ties to preventative care.   Can…

Spain Ricardo Martinez Murillo, director of the Cajal Institute – a neuroscience research center assigned to the Spanish Research Council (CSIC) and the oldest neurobiology research center in Spain – discusses recent breakthroughs in the field of neuroscience and highlights how better facilities and resources are paramount to making Spain a…

China Yuan Qing, President of the Shenzhen Life Science and Biotechnology Association, shares his insights on the characteristics of the life sciences environment in Shenzhen, the importance of the sectors as a key strategic priority for national and municipal governments, and his final message of confidence regarding the Shenzhen life science…

Baltics Piret Hirv, Health Technology Division manager at Tallinn Science Park Tehnopol, discusses the match-making role that the Estonian Connected Health Cluster provides between companies and investors and sees as a priority a less Tallinn-centered approach as a way to attract an even more diverse range of organizations. Can you give…

Brazil The Latin American pharmaceutical market in comparison. Brazil is by far the largest market. GDP real growth in Latin America regional comparison. Top 20 pharma companies in Latin America. Sanofi leads the way followed by Novartis and GSK. Brazil GDP and pharmaceutical market growth between 2014 and 2017. The evolution…

Canada At the company’s 40th anniversary, Biogen’s Canadian head Marina Vasiliou gives an insight into her priorities as new managing director, her approach to building relationships with all stakeholders in the healthcare system to ensure access to Biogen’s innovative treatments, and explains how the portfolio of the neuroscience leader is perfectly…

UK British consultant, speaker and author, Richard Barker – a key opinion leader on UK healthcare – gives his take on the recently launched ‘Life Sciences Industrial Strategy’, the importance of facilitating accelerated access to medicines, and the potential fallout from Brexit to the UK’s life sciences ecosystem.   On the…

UK Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in close adjacency to the most successful basic science programmes in biomedicinein the world. The co-location of pharmaceutical discovery sciences adjacent to the best universities (AstraZeneca in Cambridge, Novo Nordisk…

Canada Dr. David Goodman, CEO of Pharmascience, talks about the strategy for the international expansion of the company, key for which are long-lasting partnerships. He also analyzes the re-organization of the company amongst the two main axes of generics and branded products and highlights its dedication to R&D, especially in the…